Dr. Negar Asdaghi
@NAsdaghi
Mother, wife, Associate Professor of Neurology, Stroke Section Editor, Host of Strokealert podcast, University of Miami, Miller School of Medicine
This is the latest in stroke @StrokeAHA_ASA #stayalertwithstrokealert #podcast #stroke #ISC22
An honor to host @amrsarrajMD on the podcast to answer many important questions on EVT for large core. Does age, hypodensity index, NIHSS and core size modify outcomes? What about thrombolysis if eligible @NKrementzMD @CT_LP_MRI @StrokeMiami
The July episode of the #StrokeAlert Podcast is now available. Host @NAsdaghi highlights articles in the July issue of #Stroke and interviews @amrsarrajMD on “Mechanical Thrombectomy for Large Ischemic Stroke.” #AHAJournals #StayAlertWithStrokeAlert ahajournals.org/do/10.1161/pod…
Stay alert with stroke-alert @NKrementzMD @CT_LP_MRI @StrokeAHA_ASA
ICYMI: Check out the June episode of the #StrokeAlert Podcast. In this episode, host @NAsdaghi addresses these three questions. ahajournals.org/do/10.1161/pod… #stroke #AHAJournals #StayAlertWithStrokeAlert @CT_LP_MRI @NKrementzMD
#MondayTip 📊Pooled INTERACT data ✅Intensive BP lowering improves recovery in ICH ⏱️When started <3h (cutoff: 2.6h)➡️reduces haematoma growth ☝️Greatest benefit in mild–moderate ICH (ICH score) 🚨Early treatment improves outcomes👉supports CODE-ICH systems & future trial design
An official welcome to our assistant editor @CT_LP_MRI @StrokeAHA_ASA @StrokeMiami podcasts.apple.com/us/podcast/str…
What is the difference bw futile recanalization and the no reflow phenomenon? Learn this and a lot more with the June issue of #strokealert podcast.
The June episode of the #StrokeAlert Podcast is now available. @NAsdaghi highlights articles in the June issue of #Stroke & interviews Drs. Samantha Rivet & Felix Ng about "Persistent Tissue-Level Hypoperfusion (No-Reflow) Negates the Clinical Benefit of Successful Thrombectomy."
Intensive BP reduction x24hr post EVT didn’t improve outcomes. Didn’t reduce sICH. mRS 3-6 occurred in 71.0% (130/183) of the intensive-management group and 67.5% (135/200) of the standard-management group. @TheLancet
Early intensive blood pressure management after endovascular treatment in ischaemic stroke (IDENTIFY): a multicentre, open-label, blinded-endpoint, randomised controlled trial - The Lancet Regional Health – Western Pacific thelancet.com/journals/lanwp…
Very informative current issue podcast on #StrokeAlert There is discussion of the MIND study for ICH evacuation and nuances regarding its interpretation and differences between MIND and ENRICH. Dr David Fiorella interviewed @StrokeAHA_ASA @NAsdaghi
ICYMI: Intracranial hemorrhage was independently associated with a 2-fold increased risk of incident dementia — independent of the ICH subtype. #stroke #AHAJournals ahajournals.org/doi/10.1161/ST… #CME available: ahajournals.org/doi/cme/10.116…
Patients presenting with NIHSS >20 and large core did not benefit from EVT. Analysis of ANGEL ASPECTS trial. Learn this and much more @StrokeAHA_ASA strokealert podcast.
📣The April episode of the #StrokeAlert Podcast is now available. In this episode, @NAsdaghi highlights articles in the April issue of #Stroke and interviews Dr. Roland Veltkamp about the PRESTIGE-AF trial. #AHAJournals #StayAlertWithStrokeAlert ahajournals.org/do/10.1161/pod…
Very informative #StrokeAlert podcast with @NAsdaghi and Drs Goyal and Hill. Discussed lessons learned from MeVO trials and the path forward @CSC_Stroke @StrokeAHA_ASA @ESOstroke
Please help us welcome Natalia S. Rost, MD, MPH, FAAN, FAHA, as the 39th president of the American Academy of Neurology! hubs.la/Q03gM8Jx0 Welcome, @NataliaSRost! #NeurologyProud #Neurology #NeuroTwitter
One third of endovascularly treated patients in routine care are older than 80. EVT is safe in the elderly, but advanced age is a powerful predictor of poor outcomes. @FLStrokeReg @UMiamiNeuro @StrokeMiami @SharashidzeVera
In 20,000+ cases, 1 in 3 EVT patients are over 80. While EVT is safe, advanced age predicts worse outcomes. #AHAJournals @SharashidzeVera @NAsdaghi @UMiamiNeuro @NYUneurologyres @nyugrossman ahajrnls.org/3Yvqr4H
Stroke neurologist reading a CXR. Good News there is a loop recorder ( albeit low lying position). Bad News, can’t get an MRI due to bullet fragments. @StrokeMiami
Last date for ISC session submissions is tomorrow!!! This is your chance to shape ISC2026! @StrokeAHA_ASA @LaurenHSansing @NguyenThanhMD @ChaturvediNeuro @AHAScience
ahajournals.org/doi/10.1161/JA… One in 3 patients receiving endovascular thrombectomy in clinical practice are over the age of 80 years. Our findings emphasize that EVT maintains its safety across the spectrum of age in routine clinical practice. @NAsdaghi @FLStrokeReg @JAHA_AHA
Factors Associated With Stroke Recurrence After Initial Diagnosis of Cervical Artery Dissection | Stroke ahajournals.org/doi/full/10.11…
Thanks again to all for a wonderful visit! @NAsdaghi @DrJRomanoNeuro @vdelbrutto @dyavagal @NicoleBSur @StrokeMiami
Honored to have presented the preliminary data on #TRIMIS at the #ISC2025. Most patients with mild stroke and target occlusion don’t conform to incl/excl criteria of ongoing RCT. Stay tuned 4more @NguyenThanhMD @ShadiYaghi2 @UMiamiNeuro @StrokeMiami @StrokeAHA_ASA
We recently spoke w/ the lovely @NAsdaghi (@umiamimedicine) to hear preliminary findings from the TRIMIS study investigating the clinical & radiographic characteristics of mild strokes that present w/ a target occlusion. Watch here: 👉 ow.ly/NQsh50VbFch #ISC2025 #stroke
Absolutely honoured to be delivering the inaugural Ralph Sacco Distinguished Lecture at the @UMiamiNeuro 58th Neurology Update & Stroke Intensive Review. Huge thanks to @NAsdaghi & @DrJRomanoNeuro for the generous invitation and gracious hospitality! @machealthsci @PHRIresearch
Join us for Dr. Shoamanesh’s presentation on the latest advances in therapies. Only at the Neurology Update 2025 on March 8 @ 10:35am.
DOAC in survivors of ICH with Afib. An honor to host Professor Veltkamp on #strokealert podcast to discuss the results of PRESTIGE-AF @TheLancet @StrokeAHA_ASA thelancet.com/journals/lance…